Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review

Date: September 27, 2016
Pages: 44
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P48718E69CBEN
Leaflet:

Download PDF Leaflet

Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review
Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Panacea Biotec Limited (Panacea) is a research-based health management company which focuses on the research, development, manufacturing and commercialization of pharmaceuticals, biopharmaceuticals, vaccines and natural/indigenous products. Its vaccines portfolio includes paediatric vaccines, namely, trivalent and monovalent oral polio vaccine, and Enivac HB vaccine; combinative vaccines, namely Easyfive-TT (DTwP-HepB-Hib), NOVOHIB (Haemophilus Typeb Conjugate Vaccine IP) and Polprotec (Inactivated Poliomyelitis Vaccine). It offers pharmaceutical formulations in the areas of oncology, nephrology, organ transplant, pain management and diabetes management. The company also offers contract research and manufacturing services. Panacea develops these products through its research and development, and cGMP manufacturing facilities. It operates along with its subsidiaries in India, Switzerland and Germany. Panacea is headquartered in New Delhi, India.

Panacea Biotec Limited Key Recent Developments

Feb 12, 2016: Panacea Biotec Appoints Board Of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Panacea Biotec Limited - Key Facts
Panacea Biotec Limited - Key Employees
Panacea Biotec Limited - Key Employee Biographies
Panacea Biotec Limited - Major Products and Services
Panacea Biotec Limited - Pharmaceutical Pipeline Products Data
Panacea Biotec Limited, Pipeline Products by Therapy Area
Panacea Biotec Limited, Pipeline Products by Development Phase
Panacea Biotec Limited - History
Panacea Biotec Limited - Company Statement
Panacea Biotec Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Panacea Biotec Limited - Business Description
Panacea Biotec Limited - Corporate Strategy
Panacea Biotec Limited - SWOT Analysis
SWOT Analysis - Overview
Panacea Biotec Limited - Strengths
Strength - Core Segment: Pharmaceuticals Formulations
Strength - Robust R&D Facilities
Strength - Dominant Market Position
Panacea Biotec Limited - Weaknesses
Weakness - History of Losses
Panacea Biotec Limited - Opportunities
Opportunity - New Contract
Opportunity - Product Launches
Opportunity - Indian Pharmaceutical Market
Panacea Biotec Limited - Threats
Threat - Competitive Pressures
Threat - Counterfeit Drugs
Threat - Uncertain R&D Outcomes
Panacea Biotec Limited - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Panacea Biotec Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Panacea Biotec Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Panacea Biotec Limited, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 12, 2016: Panacea Biotec Appoints Board Of Directors

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Panacea Biotec Limited, Key Facts
Panacea Biotec Limited, Key Employees
Panacea Biotec Limited, Key Employee Biographies
Panacea Biotec Limited, Major Products and Services
Panacea Biotec Limited, Number of Pipeline Products by Therapy Area
Panacea Biotec Limited, Number of Pipeline Products by Development Stage
Panacea Biotec Limited, Pipeline Products By Therapy Area and Development Phase
Panacea Biotec Limited, History
Panacea Biotec Limited, Other Locations
Panacea Biotec Limited, Subsidiaries
Panacea Biotec Limited, Joint Venture
Panacea Biotec Limited, Key Competitors
Panacea Biotec Limited, Ratios based on current share price
Panacea Biotec Limited, Annual Ratios
Panacea Biotec Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Panacea Biotec Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Panacea Biotec Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Panacea Biotec Limited, Pipeline Products by Therapy Area
Panacea Biotec Limited, Pipeline Products by Development Phase
Panacea Biotec Limited, Performance Chart (2012 - 2016)
Panacea Biotec Limited, Ratio Charts
Panacea Biotec Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Panacea Biotec Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Zydus Cadila Healthcare Limited
Indus Biotech Private Limited
GlaxoSmithKline Pharmaceuticals Limited
Elder Pharmaceuticals Ltd.
Dalas Biotech
Skip to top


Ask Your Question

Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: